Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 18.44M P/E - EPS this Y 35.40% Ern Qtrly Grth -
Income -13.47M Forward P/E -2.06 EPS next Y 33.30% 50D Avg Chg -17.00%
Sales 2.82M PEG - EPS past 5Y - 200D Avg Chg -27.00%
Dividend N/A Price/Book 3.20 EPS next 5Y - 52W High Chg -64.00%
Recommedations 3.00 Quick Ratio 2.33 Shares Outstanding 25.93M 52W Low Chg 31.00%
Insider Own 12.10% ROA -109.49% Shares Float 19.52M Beta 1.06
Inst Own 25.67% ROE -214.01% Shares Shorted/Prior 308.54K/156.78K Price 1.05
Gross Margin -217.56% Profit Margin - Avg. Volume 175,337 Target Price 3.15
Oper. Margin -346.80% Earnings Date May 9 Volume 270,490 Change -0.94%
About NeuroOne Medical Technologies C

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

NeuroOne Medical Technologies C News
04/10/24 NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
04/09/24 NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
04/04/24 NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.
03/26/24 NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
03/08/24 NeuroOne® to Participate in the 36th Annual Roth Conference
02/23/24 NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
02/15/24 NeuroOne Medical Technologies First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
02/13/24 NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
02/08/24 NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13
12/14/23 NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update
12/11/23 NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System
12/07/23 NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14
11/16/23 NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe
11/14/23 NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
11/07/23 NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System
10/13/23 NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023
09/15/23 Insider Buying: CFO Ronald Mcclurg Acquires 50,900 Shares of NeuroOne Medical Technologies Corp ...
09/06/23 NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08/14/23 NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
08/08/23 NeuroOne® to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14
NMTC Chatroom

User Image SSMON Posted - 1 day ago

$NMTC BIG week next week with multiple updates on the horizon. Reached out to investor relations and be prepared for positive news!🚀🚀

User Image Wisenheimer Posted - 1 day ago

$NMTC more insider selling last week

User Image TNE222 Posted - 2 days ago

$NMTC huge volume spike end of day. 🤔

User Image SSMON Posted - 3 days ago

$NMTC Looking for an update form the company soon! This will run fast.

User Image Dammitt Posted - 1 week ago

$NMTC 1.18 is an issue.

User Image Dammitt Posted - 1 week ago

$NMTC $TWG ripping..nice

User Image Dammitt Posted - 1 week ago

$NMTC aren't shorts tired of sitting around 😴 🙄 😒. Waiting this baby out. A buyout would be 🥳🥳

User Image INcognitoBull Posted - 1 week ago

$NMTC https://www.mayoclinic.org/tests-procedures/ablation-therapy/doctors-departments/pdc-20385073

User Image SSMON Posted - 1 week ago

$NMTC this will have a nice increase up with or without news! Only good news on the horizon! 🚀🧨

User Image INcognitoBull Posted - 1 week ago

$NMTC results of the first human use cases coming soon.....OneRF being used at Mayo on epilepsy patients

User Image INcognitoBull Posted - 1 week ago

$NMTC

User Image SSMON Posted - 2 weeks ago

$NMTC don’t understand the selling here. Unless they just want cheap shares. Only good things to come from this company $NMTC This should bounce nicely next week.

User Image Wisenheimer Posted - 2 weeks ago

$NMTC given the amount of volume at $1.30 looks like atm still active

User Image INcognitoBull Posted - 2 weeks ago

$NMTC

User Image INcognitoBull Posted - 2 weeks ago

$NMTC very good interview yesterday. 👏

User Image Stock_Titan Posted - 2 weeks ago

$NMTC NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology https://www.stocktitan.net/news/NMTC/neuro-one-r-ceo-dave-rosa-featured-on-bloomberg-6cjzxhpzbiss.html

User Image Dammitt Posted - 2 weeks ago

$NMTC $SILO

User Image Dammitt Posted - 2 weeks ago

$NMTC good news today and very little hype.

User Image INcognitoBull Posted - 2 weeks ago

$NMTC we're not a "retail" stock, we don't grab the excited/FOMO wave. It's the institutions that will see this and load. It's kinda nice to not be over-run with bears.

User Image JarradM8 Posted - 2 weeks ago

$NMTC let’s gooooo

User Image G101SPM Posted - 2 weeks ago

$NMTC $1.22. DAC (dollar average cost) (6) (means 6 times we added to position) $1.345. EXIT $25.00 as long term Legacy Holding - LH. UPDATE: NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes. note: The OneRF™ Ablation System is NeuroOne’s first device with a therapeutic indication and its third FDA 510(k)-cleared device. NeuroOne now boasts a full line of thin film electrode technology to address patients requiring diagnostic brain mapping procedures as well as RF ablation using the same sEEG electrode. NeuroOne’s other FDA-cleared devices include the Evo® cortical and sEEG electrode product lines which are used primarily for stimulation, recording and monitoring of electrical activity in the brain for less than 30 days. ^NeuroOne estimates the current brain ablation market to be at least $100M worldwide and growing rapidly, with the potential to grow multifold based on large addressable patient populations with unmet clinical needs.

User Image Stock_Titan Posted - 2 weeks ago

$NMTC NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes https://www.stocktitan.net/news/NMTC/neuro-one-r-announces-first-implant-of-one-rf-ablation-z3r2ovp7lvlm.html

User Image JarradM8 Posted - 2 weeks ago

$NMTC a lot of sideways action often leading to a major move incoming 🚀

User Image MakingMeMeoutofME Posted - 2 weeks ago

$PGY $NMTC $DTSS trades for the week

User Image MakingMeMeoutofME Posted - 2 weeks ago

$NMTC looking at chart I see 1.55-1.75 in 5-10 trading days just like $NXL $DTSS

User Image Wisenheimer Posted - 3 weeks ago

$NMTC right back to $1

User Image Painman Posted - 3 weeks ago

$NMTC ..Love the concept but this is going to take some time

User Image Painman Posted - 3 weeks ago

$NMTC ..Great concept..IF it works..Has not been tested on a Human brain yet so hopefully they get a good result

User Image Stock_Titan Posted - 3 weeks ago

$NMTC NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co. https://www.stocktitan.net/news/NMTC/neuro-one-r-ceo-dave-rosa-featured-on-fox-business-network-s-varney-fxmpswz97ok3.html

User Image JarradM8 Posted - 3 weeks ago

$NMTC breakout soon

Analyst Ratings
Alliance Global Partners Buy Aug 15, 23
Craig-Hallum Hold Mar 28, 22
Alliance Global Partners Buy Dec 3, 21
Craig-Hallum Buy Nov 15, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Christianson Mark Business Development.. Business Development Director Dec 26 Sell 1.41 38,293 53,993 300,594 12/27/23
McClurg Ronald W. Chief Financial Offi.. Chief Financial Officer Sep 13 Buy 0.9828 50,900 50,025 130,400 09/14/23
Christianson Mark Business Development.. Business Development Director Mar 21 Sell 1.54 26,500 40,810 337,494 03/24/23
McClurg Ronald W. Chief Financial Offi.. Chief Financial Officer Jun 15 Buy 1.0219 10,000 10,219 67,000 06/16/22
Christianson Mark Business Development.. Business Development Director Jun 23 Sell 6.52 11,900 77,588 351,169 02/04/22